Lenti:FlipGFP-T2A-mCherry
(Plasmid
#223198)
-
PurposeLentiviral vector encoding FlipGFP-T2A-mCherry (w/ caspase-3 cleave site in FlipGFP for restoring GFP conformation)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 223198 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneAddgene #61422
-
Backbone manufacturerAddgene
-
Modifications to backbonedCas9VP64-T2A-EGFP in Addgene #61422 was swapped with FlipGFP-T2A-mCherry (retrieved from Addgene #124428)
-
Vector typeMammalian Expression, Lentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameFlipGFP-T2A-mCherry
-
SpeciesSynthetic
- Promoter EF1a
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BsiWI (not destroyed)
- 3′ cloning site EcoRI (not destroyed)
- 5′ sequencing primer TCAAGCCTCAGACAGTGGTTC (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byXiaokun Shu and Feng Zhang (Addgene plasmids #124428 and #61422 respectively).
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Lenti:FlipGFP-T2A-mCherry was a gift from Yeh-Hsing Lao (Addgene plasmid # 223198 ; http://n2t.net/addgene:223198 ; RRID:Addgene_223198) -
For your References section:
Enabling continuous immune cell recirculation on a microfluidic array to study immunotherapeutic interactions in a recapitulated tumour microenvironment. Chi CW, Lao YH, Ahmed AHR, He S, Merghoub T, Leong KW, Wang S. Lab Chip. 2024 Jan 30;24(3):396-407. doi: 10.1039/d3lc00662j. 10.1039/d3lc00662j PubMed 38180130